RBC Global Healthcare Conference: US Large Cap Pharma Analyst Trung Huynh shares his take on the obesity market and rates Pfizer's last two major acquisitions
- May 19
- 1 min read
He discusses Lilly (his top pick) and the launch of Foundayo, and shares how he thinks about Pfizer's last two large acquisitions for Metsera and Seagen.











.png)